STAT3 (Phospho_Ser727) Antibody
- Known as:
- STAT3 (Phospho_Ser727) Antibody
- Catalog number:
- E011046-2
- Product Quantity:
- 100ug
- Category:
- Antibodies
- Supplier:
- EnoGene
- Gene target:
- STAT3 (Phospho_Ser727) Antibody
Related genes to: STAT3 (Phospho_Ser727) Antibody
- Gene:
- STAT3 NIH gene
- Name:
- signal transducer and activator of transcription 3
- Previous symbol:
- -
- Synonyms:
- APRF
- Chromosome:
- 17q21.2
- Locus Type:
- gene with protein product
- Date approved:
- 1995-11-08
- Date modifiied:
- 2019-04-23
Related products to: STAT3 (Phospho_Ser727) Antibody
Related articles to: STAT3 (Phospho_Ser727) Antibody
- Chlorella polysaccharide extract (CPE) is a natural compound with known antioxidant and immunomodulatory properties. This study investigated its anti-aging potential and underlying mechanism, with a focus on dermatological relevance. - Source: PubMed
Zhang MinghuiGuo YalingJiang XufengLi ZhouxinXiang GuanggangLin YewenZhang Yang - Mutations in cytokine receptor and JAK/STAT; Cy-JAK/STAT) signaling genes drive myeloproliferative neoplasms (MPNs) but remain incompletely characterized in acute myeloid leukemia (AML). The authors evaluated the prevalence, clinical presentation, and prognostic significance of Cy-JAK/STAT pathway mutations in patients with AML and compared outcomes across disease ontogeny. - Source: PubMed
Albliwi MoathNurse Daniel PZabor Emily CHanna JohnEl-Asmar JessicaBawwab AmeedAbuamsha HasanAbu-Farsakh YomnaBatah HeyaRauf AsadNakitandwe JoyBosler David SParthasarathy Prerana BangaloreAlban TylerJain Akriti GMolina John CBalderman SophiaSingh AbhayGerds Aaron TMukherjee SudiptoAdvani Anjali SCarraway Hetty EMustafa Ali Moaath K - Psoriasis is an immune-mediated chronic inflammatory skin disease. Existing therapies have limitations, necessitating the development of new treatment approaches. Compound Baixianpi Formula (FFBXP) is a clinically effective topical Chinese herbal formula, but its material basis and mechanism of action remain unclear. - Source: PubMed
Publication date: 2026/05/22
Tang LinWang YanliZhou YueGan ChunliWang Jinhui - Glioblastoma (GBM) relapse and drug resistance are driven by a subset of quiescent, therapy-tolerant cells that persist in the G0 phase. However, the molecular mechanism coupling immune signaling to tumor cell quiescence and metabolic adaptation remains unclear. - Source: PubMed
Publication date: 2026/05/22
Qian YuZhao Kai - Vascular invasion critically determines intrahepatic and extrahepatic metastasis and early recurrence in hepatocellular carcinoma (HCC), yet its underlying mechanisms remain poorly defined. In this study, we employed EdU proliferation, colony formation, wound healing, transwell, spheroid formation, and immunofluorescence assays, along with xenograft tumor and liver/lung metastasis models, immunohistochemistry, and western blotting to investigate the biological functions of tissue factor (TF) and the therapeutic potential of targeting TF and its downstream signaling. Our results demonstrate that TF is upregulated in HCC tissues and correlates with poor prognosis. TF overexpression significantly enhanced HCC cell proliferation, migration, invasion, and spheroid formation in vitro, and promoted tumor growth and metastasis in vivo. Clinical sample analysis further revealed that high TF expression increases the dissemination potential of circulating tumor cells (CTCs) and circulating tumor microemboli (CTMs) in peripheral blood, thereby facilitating hematogenous spread. Mechanistically, TF activates PAR1 on HCC cell surfaces, leading to activation of both the Wnt/β-catenin and JAK2/STAT3 pathways, with nuclear translocation and accumulation of β-catenin and STAT3. Notably, nuclear STAT3 enhances TF promoter activity, forming a positive feedback loop that sustains downstream signaling. TF also promotes extracellular matrix degradation. Importantly, combined inhibition of TF with β-catenin and STAT3 blockers effectively suppressed HCC tumorigenesis and metastasis both in vitro and in vivo. These findings elucidate the oncogenic role of TF in vascular invasion-mediated HCC metastasis and suggest a promising combinatorial therapeutic strategy for HCC treatment. - Source: PubMed
Publication date: 2026/05/23
Wang Wen-ChaoJi Wei-DanMa Jun-YongPan YunChen LeiLin Xue-JingChen YingTang MinLiu Hai-LongLin Mou-BinZhang Xiao-FengSun Bin